159 related articles for article (PubMed ID: 19125641)
21. Monensin inhibits catecholamine synthesis in pheochromocytoma cells.
Vaccaro KK; Liang BT; Sheard BE; Perlman RL
J Pharmacol Exp Ther; 1982 Jun; 221(3):536-40. PubMed ID: 6123583
[TBL] [Abstract][Full Text] [Related]
22. The norepinephrine transporter and pheochromocytoma.
Cleary S; Phillips JK
Ann N Y Acad Sci; 2006 Aug; 1073():263-9. PubMed ID: 17102094
[TBL] [Abstract][Full Text] [Related]
23. Release and metabolism of dopamine in a clonal line of pheochromocytoma (PC12) cells exposed to fenthion.
Tuler SM; Hazen AA; Bowen JM
Fundam Appl Toxicol; 1989 Oct; 13(3):484-92. PubMed ID: 2612780
[TBL] [Abstract][Full Text] [Related]
24. Effect of atrial natriuretic peptide on catecholamine release from human pheochromocytoma.
Nakamaru M; Ogihara T; Saito H; Rakugi H; Hashizume K; Yamatodani A; Wada H; Kumahara Y
Acta Endocrinol (Copenh); 1989 Jan; 120(1):107-12. PubMed ID: 2521413
[TBL] [Abstract][Full Text] [Related]
25. Possible autocrine enkephalin regulation of catecholamine release in human pheochromocytoma cells.
Pellizzari EH; Barontini M; Figuerola Mde L; Cigorraga SB; Levin G
Life Sci; 2008 Sep; 83(11-12):413-20. PubMed ID: 18706432
[TBL] [Abstract][Full Text] [Related]
26. Pathologic and cardiovascular characterization of pheochromocytoma-associated cardiomyopathy in dogs.
Edmondson EF; Bright JM; Halsey CH; Ehrhart EJ
Vet Pathol; 2015 Mar; 52(2):338-43. PubMed ID: 24810909
[TBL] [Abstract][Full Text] [Related]
27. Alteration of catecholamines in pheochromocytoma (PC12) cells in vitro by the metabolites of chlorotriazine herbicide.
Das PC; McElroy WK; Cooper RL
Toxicol Sci; 2001 Jan; 59(1):127-37. PubMed ID: 11134552
[TBL] [Abstract][Full Text] [Related]
28. Release of (3H)norepinephrine from a clonal line of pheochromocytoma cells (PC12) by nicotinic cholinergic stimulation.
Greene LA; Rein G
Brain Res; 1977 Dec; 138(3):521-8. PubMed ID: 597722
[TBL] [Abstract][Full Text] [Related]
29. Pathological Aspects and Immunohistochemical Evaluation of Troponin C in the Cardiovascular System of Dogs With Pheochromocytoma.
Argenta FF; Slaviero M; de Mello LS; Echenique JVZ; Zorzan AA; Cony FG; Bandinelli MB; de Castro MB; Pavarini SP; Driemeier D; Sonne L
Top Companion Anim Med; 2023; 53-54():100777. PubMed ID: 37030618
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
31. Lack of miR-133a Decreases Contractility of Diabetic Hearts: A Role for Novel Cross Talk Between Tyrosine Aminotransferase and Tyrosine Hydroxylase.
Nandi SS; Zheng H; Sharma NM; Shahshahan HR; Patel KP; Mishra PK
Diabetes; 2016 Oct; 65(10):3075-90. PubMed ID: 27411382
[TBL] [Abstract][Full Text] [Related]
32. Muscarinic stimulation of calcium influx and norepinephrine release in PC12 cells.
Inoue K; Kenimer JG
J Biol Chem; 1988 Jun; 263(17):8157-61. PubMed ID: 2453511
[TBL] [Abstract][Full Text] [Related]
33. The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues.
Zeng ZP; Liu GQ; Li HZ; Fan XR; Liu DM; Tong AL; Zheng X; Liu C
Ann N Y Acad Sci; 2006 Aug; 1073():284-9. PubMed ID: 17102097
[TBL] [Abstract][Full Text] [Related]
34. Lack of leptin suppression in response to hypersecretion of catecholamines in pheochromocytoma patients.
Böttner A; Eisenhofer G; Torpy DJ; Ehrhart-Bornstein M; Keiser HR; Chrousos GP; Bornstein SR
Metabolism; 1999 May; 48(5):543-5. PubMed ID: 10337850
[TBL] [Abstract][Full Text] [Related]
35. Effects of norepinephrine on apoptosis in rat neonatal cardiomyocytes.
Shyu KG; Kuan P; Chang ML; Wang BW; Huang FY
J Formos Med Assoc; 2000 May; 99(5):412-8. PubMed ID: 10870332
[TBL] [Abstract][Full Text] [Related]
36. Orexins suppress catecholamine synthesis and secretion in cultured PC12 cells.
Nanmoku T; Isobe K; Sakurai T; Yamanaka A; Takekoshi K; Kawakami Y; Ishii K; Goto K; Nakai T
Biochem Biophys Res Commun; 2000 Aug; 274(2):310-5. PubMed ID: 10913336
[TBL] [Abstract][Full Text] [Related]
37. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
[TBL] [Abstract][Full Text] [Related]
38. Tetanus toxin affects the K+-stimulated release of catecholamines from nerve growth factor-treated PC12 cells.
Figliomeni B; Grasso A
Biochem Biophys Res Commun; 1985 Apr; 128(1):249-56. PubMed ID: 3985967
[TBL] [Abstract][Full Text] [Related]
39. Symptoms of pheochromocytoma, with particular reference to headache, correlated with catecholamine production.
Lance JW; Hinterberger H
Arch Neurol; 1976 Apr; 33(4):281-8. PubMed ID: 1259642
[TBL] [Abstract][Full Text] [Related]
40. Interferon alpha and rapamycin inhibit the growth of pheochromocytoma PC12 line in vitro.
Motylewska E; Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Niedziela A; Melen-Mucha G; Stepien H
Endokrynol Pol; 2013; 64(5):368-74. PubMed ID: 24186594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
